Published in Am Heart J on October 01, 1985
Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor. Science (1997) 4.03
Report of the American Society of Echocardiography Committee on Nomenclature and Standards in Two-dimensional Echocardiography. Circulation (1980) 3.87
Echocardiographic measurements in normal subjects from infancy to old age. Circulation (1980) 3.55
Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS. Circulation (1973) 3.31
The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature. Am J Med (1979) 2.86
Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science (1999) 2.43
Comparative left ventricular dimensions in trained athletes. Ann Intern Med (1975) 2.27
Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation (1976) 2.08
Temporal expression of different pathways of 1-arginine metabolism in healing wounds. J Immunol (1990) 2.06
Echocardiographic measurements in normal subjects. Growth-related changes that occur between infancy and early adulthood. Circulation (1978) 2.05
Familial prevalence and genetic transmission of idiopathic hypertrophic subaortic stenosis. N Engl J Med (1973) 1.96
Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients. Circulation (1975) 1.96
Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Light and electron microscopic findings. Circulation (1974) 1.85
Arginine metabolism in wounds. Am J Physiol (1988) 1.81
Evaluation of pulmonary artery pressure and resistance by pulsed Doppler echocardiography. Am J Cardiol (1987) 1.78
HIF-1 expression in healing wounds: HIF-1alpha induction in primary inflammatory cells by TNF-alpha. Am J Physiol Cell Physiol (2001) 1.61
Asymetric septal hypertrophy in childhood. Circulation (1976) 1.56
Asymmetric septal hypertrophy (ASH): the unifying link in the IHSS disease spectrum. Observations regarding its pathogenesis, pathophysiology, and course. Circulation (1973) 1.55
Echocardiographic measurement of the left ventricular outflow gradient in idiopathic hypertrophic subaortic stenosis. N Engl J Med (1973) 1.52
Protein repletion and treatment in anorexia nervosa. Am J Clin Nutr (1994) 1.50
Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation. Am J Cardiol (1989) 1.50
Regulation of macrophage functions by L-arginine. J Exp Med (1989) 1.49
Measurement of mitral orifice area in patients with mitral valve disease by real-time, two-dimensional echocardiography. Circulation (1975) 1.49
Echocardiographic measurements in normal subjects: evaluation of an adult population without clinically apparent heart disease. J Clin Ultrasound (1979) 1.46
Total-body nitrogen by neutron activation in maintenance dialysis. Am J Kidney Dis (1990) 1.43
Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects. Circulation (1979) 1.42
Comparing different methods of assessing body composition in end-stage renal failure. Kidney Int (2000) 1.42
Comparison of echocardiographic and necropsy measurements of ventricular wall thicknesses in patients with and without disproportionate septal thickening. Circulation (1977) 1.41
Distinct arginase isoforms expressed in primary and transformed macrophages: regulation by oxygen tension. Am J Physiol (1998) 1.32
Mechanism of left ventricular outlfow obstruction in patients with obstructive asymmetric septal hypertrophy (idiopathic hypertrophic subaortic stenosis). Am J Cardiol (1975) 1.31
Observations on the optimum time for operative intervention for aortic regurgitation. I. Evaluation of the results of aortic valve replacement in symptomatic patients. Circulation (1980) 1.22
Evaluation of the ability of echocardiography to measure acute alterations in left ventricular volume. Circulation (1974) 1.21
MUC1 expression in primary and metastatic pancreatic cancer cells for in vitro treatment by (213)Bi-C595 radioimmunoconjugate. Br J Cancer (2004) 1.17
Exercise-induced left ventricular dysfunction in symptomatic and asymptomatic patients with aortic regurgitation: assessment with radionuclide cineangiography. Am J Cardiol (1978) 1.17
Life-threatening ventricular arrhythmias due to transient or correctable causes: high risk for death in follow-up. J Am Coll Cardiol (2001) 1.16
Asymmetric septal hypertrophy (ASH) in infancy. Circulation (1974) 1.15
A simple Doppler echocardiographic method for estimating severity of aortic regurgitation. Am J Cardiol (1986) 1.14
Identification of congenital malformations of the great arteries in infants by real-time two-dimensional echocardiography. Circulation (1975) 1.14
Factors influencing blood pressure in salt-sensitive patients with hypertension. Am J Med (1980) 1.14
Regulation of macrophage physiology by L-arginine: role of the oxidative L-arginine deiminase pathway. J Immunol (1989) 1.13
Prevalence and characteristics of disproportionate ventricular septal thickening in patients with acquired or congenital heart diseases: echocardiographic and morphologic findings. Circulation (1977) 1.12
Electrocardiographic findings in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation (1978) 1.12
Determination of skeletal muscle and fat-free mass by nuclear and dual-energy x-ray absorptiometry methods in men and women aged 51-84 y (1-3). Am J Clin Nutr (1999) 1.11
Doppler color flow "proximal isovelocity surface area" method for estimating volume flow rate: effects of orifice shape and machine factors. J Am Coll Cardiol (1991) 1.11
Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway. J Surg Res (1991) 1.10
Observations on the optimum time for operative intervention for aortic regurgitation. II. Serial echocardiographic evaluation of asymptomatic patients. Circulation (1980) 1.10
Tunnel subaortic stenosis: left ventricular outflow tract obstruction produced by fibromuscular tubular narrowing. Circulation (1976) 1.10
Evaluation of blood flow velocity in the ascending aorta and main pulmonary artery of normal subjects by Doppler echocardiography. Am Heart J (1984) 1.09
Echocardiographic observations in patients with systemic infiltrative disease involving the heart. Am J Cardiol (1977) 1.09
Regulation of arginase isoforms I and II by IL-4 in cultured murine peritoneal macrophages. Am J Physiol (1999) 1.06
In vivo studies of Gd-DTPA-monoclonal antibody and gd-porphyrins: potential magnetic resonance imaging contrast agents for melanoma. J Magn Reson Imaging (2001) 1.05
Reproducibility of Doppler aortic blood flow measurements: studies on intraobserver, interobserver and day-to-day variability in normal subjects. Am J Cardiol (1984) 1.05
Changes in body composition during breast cancer chemotherapy with the CMF-regimen. Breast Cancer Res Treat (1999) 1.04
The predictive value of body protein for chemotherapy-induced toxicity. Cancer (2000) 1.04
Effects of self-induced starvation on cardiac size and function in anorexia nervosa. Circulation (1978) 1.04
Macrophage activation by culture in an anoxic environment. J Immunol (1995) 1.03
Echocardiographic abnormalities in patients with transfusion-dependent anemia and secondary myocardial iron deposition. Am J Med (1978) 1.03
Assessment of normal and atherosclerotic arterial wall thickness with an intravascular ultrasound imaging catheter. Am Heart J (1990) 1.03
Determination of boron in biological tissues by inductively coupled plasma atomic emission spectrometry. Anal Chem (1987) 1.03
The use of Doppler flow velocity measurement to assess the hemodynamic response to vasodilators in patients with heart failure. Circulation (1983) 1.02
Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Echocardiographic and gross anatomic findings. Circulation (1974) 1.02
Left ventricular outflow tract obstruction due to systolic anterior motion of the anterior mitral leaflet in patients with concentric left ventricular hypertrophy. Circulation (1978) 1.02
Magnesium therapy of cardiac arrhythmias in critical-care medicine. Magnesium (1989) 1.01
Intravascular ultrasound cross-sectional arterial imaging before and after balloon angioplasty in vitro. Circulation (1989) 1.01
Echocardiographic abnormalities in chronic alcoholics with and without overt congestive heart failure. Am J Cardiol (1981) 1.00
Life-threatening alterations in heart rate after the use of adenosine in atrial flutter. Am Heart J (1995) 0.99
Pulsed Doppler echocardiographic study of left ventricular filling in dilated cardiomyopathy. Am J Cardiol (1986) 0.99
Determinants of ventricular septal motion. Influence of relative right and left ventricular size. Circulation (1976) 0.98
Superiority of two-dimensional measurement of aortic vessel diameter in Doppler echocardiographic estimates of left ventricular stroke volume. J Am Coll Cardiol (1985) 0.98
Congenital heart malformations associated with disproportionate ventricular septal thickening. Circulation (1975) 0.97
In vitro studies of gadolinium-DTPA conjugated with monoclonal antibodies as cancer-specific magnetic resonance imaging contrast agents. Australas Phys Eng Sci Med (2002) 0.97
Computer analysis of cardiac catheterization data. Am J Cardiol (1968) 0.97
Ionic biology and ionic medicine in cardiac arrhythmias with particular reference to magnesium. Am Heart J (1992) 0.96
A pulsed Doppler echocardiographic study of the postnatal changes in pulmonary artery and ascending aortic flow in normal term newborn infants. Am Heart J (1987) 0.96
In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen. Prostate Cancer Prostatic Dis (2002) 0.96
Molecular and metabolic evidence for the restricted expression of inducible nitric oxide synthase in healing wounds. Am J Pathol (1999) 0.95
A sector scanner for real time two-dimensional echocardiography. Circulation (1974) 0.95
Ventricular tachyarrhythmia associated with psychological stress. The role of the sympathetic nervous system. JAMA (1987) 0.94
Spatial patterns of child growth in Papua New Guinea and their relation to environment, diet, socio-economic status and subsistence activities. Ann Hum Biol (2001) 0.94
Non-invasive measurement of cardiac output by a single breath constant expiratory technique. Thorax (1984) 0.93
Preoperative exercise capacity in symptomatic patients with aortic regurgitation as a predictor of postoperative left ventricular function and long-term prognosis. Circulation (1980) 0.93
Regional attitudes of generalists, specialists, and subspecialists about management of atrial fibrillation. Arch Intern Med (1997) 0.93
Left ventricular filling in hypertrophic cardiomyopathy: a pulsed Doppler echocardiographic study. J Am Coll Cardiol (1986) 0.93
Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. J Am Coll Cardiol (1999) 0.93
Fission converter and metal-oxide-semiconductor field effect transistor study of thermal neutron flux distribution in an epithermal neutron therapy beam. Med Phys (1999) 0.92
Echocardiographic comparison of black and white hypertensive subjects. J Natl Med Assoc (1979) 0.90
Relationship between age, body size, gender, and blood pressure and Doppler flow measurements in the aorta and pulmonary artery. Am Heart J (1987) 0.90
Videodensitometric determination of minimum coronary artery luminal diameter before and after angioplasty. Am J Cardiol (1987) 0.89
Delayed cardiac tamponade associated with prophylactic anticoagulation in patients undergoing coronary bypass grafting. Early diagnosis with two-dimensional echocardiography. J Thorac Cardiovasc Surg (1978) 0.89
Evaluation of aortic valve replacement in patients with valvular aortic stenosis. Circulation (1980) 0.89
Significance of magnesium in congestive heart failure. Am Heart J (1996) 0.89
Brain cancer incidence, mortality and case survival: observations from two Australian cancer registries. Int J Cancer (1994) 0.88
Magnesium sulfate therapy for sustained monomorphic ventricular tachycardia. Am J Cardiol (1989) 0.88